India is home to a vibrant Life Science and biotech industry employing over one million professionals. Bio-pharmaceuticals account for more than two-thirds of biotech activity in India. The industry is geographically diversified with hubs in Hyderabad, Bangalore, Delhi National Capital Region, Gujarat, Mumbai and outposts in Pune and elsewhere. Biotech and Bio-pharma in India are well connected globally.
Industries
Bio Pharmaceuticals Biotechnology
Key Issues
For life science companies from the USA, Canada and Europe, Contract Research Organizations (CROs), CMOs CDMOs and CRDMOs offer excellent opportunities to accelerate product development, reduce costs and broaden product offerings. At Amritt, we can help select the best matched outsourced partner and we can manage that partner. We can be your eyes and ears on the ground in India.
- India is home to dozens of such suppliers that serve tiny startups all the way to billion-dollar giants
- Many are dependent on western customers for survival and offer world-class quality
India’s bio-manufacturing capability is not fully appreciated in the west.
- The world’s two largest vaccine makers by volume are Indian companies: Serum Institute in Pune and Biological-E in Hyderabad.
- Many of India’s multi-billion-dollar generic pharmaceutical companies have had huge success in the USA and have added biologics to their offerings.
- India’s largest pure play bio-pharma company is Biocon, founded and led by Dr. Kiran Mazumdar Shaw, a larger-than-life figure; many other pure play biotech and biopharma players are present.
Today India boasts a vibrant startup bio-pharma ecosystem with dozens iof incubators and accelerators.
- A number of angels and angel funds offer seed funding
- The federal government’s Department of Biotechnology offers grant funding and startup space at facilities such as C-CAMP.
- While domestic venture funding is limited, strong Indian startups, often “flip” and incorporate a parent entity in the United States to access American investors.
- American Private Equity funds such as Advent International have acquired more mature bio-pharma companies in India.
Amritt can bring identify promising Indian startups for licensing, investment, partnership or M&A.
India’s government established the Department of Biotechnology in 1986 and has increased its annual budget to over half a billion dollars.
- In addition, bio-pharma companies need to interact with the Ministry of Environment, Ministry of Health and Ministry of Chemicals.
Amritt maintains good contacts with federal and state officials in India and with relevant trade groups.
Global Bio-pharma companies have found a good market in India.
- AbbVie, Amgen, Eli Lilly, Gilead, GSK, Johnson & Johnson, Novo Nordisk, and Sanofi are among the companies that sell products in India.
- Novartis employes over 10,000 Indians, mostly in Hyderabad. Abbott, GSK, Pfizer have plants
- With India now a top five global economy, and healthcare spending on the rise, there is opportunity for new bio-pharma entrants into India’s market.
The India Experts at Amritt can help you with any aspect of engaging with India’s biotech ecosystem.
